Travere Therapeutics Inc (TVTX): Next-Year EPS Estimate 1570.75%
As of 2026-07-31, Travere Therapeutics Inc (TVTX) has a next-year EPS growth estimate of 1570.75%. Featured in 2 EPS revision reports, most recently on 2026-04-15.
On 2026-07-30, analyst consensus for TVTX's next-year EPS growth shifted from 7084.07% to 1570.75% — a negative change of 5513.32 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 44.88%.
What's Driving This
TVTX has risen primarily on structural EPS estimate upgrades, with the current next-year growth outlook at 1570.75% after net upward revisions of 425.90 percentage points since detection. No specific recent headline ties directly to a named catalyst such as an earnings beat or guidance raise. The broader biotech sector momentum, as referenced in the earnings-season headline, may be providing additional tailwind.
Generated 2026-07-31 from news as of 2026-07-31
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 1570.75%
- EPS growth this year
- 44.88%
- EPS next quarter (est)
- -$0.13
- Last price
- $55.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-31 | 1570.75% | 44.88% | -$0.13 | $55.89 |
| 2026-07-30 | 1570.75% | 44.88% | -$0.13 | $57.28 |
| 2026-07-29 | 7084.07% | 88.09% | -$0.11 | $55.56 |
| 2026-07-28 | 1295.92% | 158.67% | -$0.10 | $55.91 |
| 2026-07-27 | 1295.92% | 158.67% | -$0.10 | $56.68 |
| 2026-07-26 | 1295.92% | 158.67% | -$0.10 | $57.36 |
| 2026-07-24 | 1295.92% | 158.67% | -$0.10 | $57.36 |
| 2026-07-23 | 1295.92% | 158.67% | -$0.10 | $56.68 |
| 2026-07-22 | 1295.92% | 158.67% | -$0.10 | $56.26 |
| 2026-07-21 | 1363.59% | 157.24% | -$0.10 | $56.58 |
| 2026-07-20 | 1363.59% | 157.24% | -$0.10 | $55.47 |
| 2026-07-19 | 1144.85% | 167.29% | -$0.08 | $56.71 |
| 2026-07-17 | 1144.85% | 167.29% | -$0.08 | $56.71 |
| 2026-07-16 | 1144.85% | 167.29% | -$0.08 | $55.28 |
| 2026-07-15 | 1144.85% | 167.29% | -$0.08 | $56.74 |
| 2026-07-14 | 1144.85% | 167.29% | -$0.08 | $57.06 |
| 2026-07-13 | 1144.85% | 167.29% | -$0.08 | $56.29 |
| 2026-07-12 | 1144.85% | 167.29% | -$0.08 | $56.59 |
| 2026-07-09 | 1144.85% | 167.29% | -$0.08 | $58.47 |
| 2026-07-08 | 1144.85% | 167.29% | -$0.08 | $58.36 |
| 2026-07-07 | 1144.85% | 167.29% | -$0.08 | $57.85 |
| 2026-07-06 | 1144.85% | 167.29% | -$0.08 | $57.48 |
| 2026-07-05 | 1144.85% | 167.29% | -$0.08 | $56.92 |
| 2026-07-02 | 1144.85% | 167.29% | -$0.08 | $56.92 |
| 2026-07-01 | 1144.85% | 167.29% | -$0.08 | $56.34 |
| 2026-06-30 | 1144.85% | 167.29% | -$0.08 | $56.81 |
| 2026-06-29 | 1144.85% | 167.29% | -$0.08 | $58.30 |
| 2026-06-28 | 1144.85% | 167.29% | -$0.08 | $58.85 |
| 2026-06-25 | 1144.85% | 167.29% | -$0.08 | $59.03 |
| 2026-06-24 | 1144.85% | 167.29% | -$0.08 | $57.69 |
Reports Featuring TVTX
Recent News
- Four Biotech Stocks Near Buy Points As Earnings Season Kicks InInvestor's Business Daily
Screen Performance
Aggregate stats across all 1903 tickers our top-EPS-revision screen has flagged over the past 121 days.
- Median return since detection
- +1.2%
- % of tickers in the green
- 52%
- Median return on winners
- +18.8%
- Large revisions captured
- 1198
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Travere Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-07-31, Travere Therapeutics Inc (TVTX) has a next-year EPS growth estimate of 1570.75%, based on analyst consensus.
When was the latest EPS estimate revision for TVTX?▾
The most recent revision occurred on 2026-07-30, when analysts adjusted the next-year EPS growth estimate from 7084.07% to 1570.75%.
What sector and industry does Travere Therapeutics Inc belong to?▾
Travere Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TVTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Travere Therapeutics Inc (TVTX) appears here because it was detected by our daily top-EPS-revision-performer screen.